Dr Ma's Laboratories, Inc. · 99-39 · CANADA
For Dr Ma's Laboratories, Inc. · 99-39 · CANADA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CANADA; product is Living Alchemy Ashwagandha | Living Alchemy Ashwagandha | Lovita Bee Propolis Liquid Extract | Lovita Bee Propolis Liquid Extract; product code is 41 B - - 99 Foods with Supplemental Nutrients Added, with or without Artifical Sweetners | 54 F - - 94 Ashwagandha (Herbal & Botanicals, not Teas) | 54 G - - 99 Animal By-Products and Extracts, N.E.C. | 54 Y - - 06 Bee Pollen (Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, N.E.C.); date published is 03/27/2025; address is 4-8118 North Fraser Way , Burnaby, British Columbia CANADA, verified against its source on 2026-09-16.
- Firm
- Dr Ma's Laboratories, Inc. verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- CANADA verified
- Address
- 4-8118 North Fraser Way , Burnaby, British Columbia CANADA verified
- Date published
- 03/27/2025 verified
- Product code
- 41 B - - 99 Foods with Supplemental Nutrients Added, with or without Artifical Sweetners | 54 F - - 94 Ashwagandha (Herbal & Botanicals, not Teas) | 54 G - - 99 Animal By-Products and Extracts, N.E.C. | 54 Y - - 06 Bee Pollen (Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, N.E.C.) each item verified
- Product
- Living Alchemy Ashwagandha | Living Alchemy Ashwagandha | Lovita Bee Propolis Liquid Extract | Lovita Bee Propolis Liquid Extract each item verified
- FDA notes
- The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the Act) in that the product appears to be misbranded within the meaning of: Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] in that the product labels fail to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the Act) in that the product appears to be misbranded within the meaning of: Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] in that the product labels fail to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the Act) in that the product appears to be misbranded within the meaning of: Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] in that the product labels fail to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. Section 403(s)(2)(B) of the Act [21 U.S.C. § 343 (s)(2)(B)] in that the label fails to include the statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. § 343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in section 761 of the Act [21 U.S.C. 379aa-1], may receive a report of a serious adverse event with such dietary supplements. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the Act) in that the product appears to be misbranded within the meaning of: Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] in that the product labels fail to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. Section 403(s)(2)(B) of the Act [21 U.S.C. § 343 (s)(2)(B)] in that the label fails to include the statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. § 343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in section 761 of the Act [21 U.S.C. 379aa-1], may receive a report of a serious adverse event with such dietary supplements. each item verified
What the source says
Dr Ma's Laboratories, Inc. Date Published : 03/27/2025 4-8118 North Fraser Way , Burnaby, British Columbia CANADA 41 B - - 99 Foods with Supplemental Nutrients Added, with or without Artifical Sweetners Date Published: 03/27/2025 Desc: Living Alchemy Ashwagandha Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the Act) in that the product appears to be misbranded within the meaning of: Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] in that the product labels fail to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. 54 F - - 94 Ashwagandha (Herbal & Botanicals, not Teas) Date Published: 03/27/2025 Desc: Living Alchemy Ashwagandha Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the Act) in that the product appears to be misbranded within the meaning of: Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] in that the product labels fail to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. 54 G - - 99 Animal By-Products and Extracts, N.E.C. Date Published: 03/27/2025 Desc: Lovita Bee Propolis Liquid Extract Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the Act) in that the product appears to be misbranded within the meaning of: Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] in that the product labels fail to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. Section 403(s)(2)(B) of the Act [21 U.S.C. § 343 (s)(2)(B)] in that the label fails to include the statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. § 343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in section 761 of the Act [21 U.S.C. 379aa-1], may receive a report of a serious adverse event with such dietary supplements. 54 Y - - 06 Bee Pollen (Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, N.E.C.) Date Published: 03/27/2025 Desc: Lovita Bee Propolis Liquid Extract Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (the Act) in that the product appears to be misbranded within the meaning of: Section 403(e)(1) of the Act [21 U.S.C. § 343 (e)(1)] in that the product labels fail to list the name and place of business of the manufacturer, packer, or distributor in accordance with 21 CFR 101.5. Section 403(s)(2)(B) of the Act [21 U.S.C. § 343 (s)(2)(B)] in that the label fails to include the statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. § 343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in section 761 of the Act [21 U.S.C. 379aa-1], may receive a report of a serious adverse event with such dietary supplements.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.